column
    Effect of establishing arteriovenous fistula on left ventricular myocardial function in uremic patients
    Chen Ai-qing, Chen Yong
    2024, 24(9): 705-711. DOI: 10.3969/j.issn.1671-2390.2024.09.001
    Abstract PDF
    Application of transesophageal echocardiography for hemodialysis tunneled cuffed catheter dysfunction
    Wang Yun-ruo, Wu You, Xu Du-juan, Liu Ru, Niu Su
    2024, 24(9): 712-719. DOI: 10.3969/j.issn.1671-2390.2024.09.002
    Abstract PDF
    Risk factors of acute kidney injury in severe COVID-19 patients and their predictive values
    Niu Dan, Zhang Yi, Dong Dao-ran
    2024, 24(9): 720-727. DOI: 10.3969/j.issn.1671-2390.2024.09.003
    Abstract PDF
    Efficacy of tacrolimus plus glucocorticoid for lupus nephritis: a Meta-analysis
    Xing Yi-xi, Chen Wei-fei, Liang Jin, Lin Qian-qi
    2024, 24(9): 728-736. DOI: 10.3969/j.issn.1671-2390.2024.09.004
    Abstract PDF
    Correlation between serum Klotho and uromodulin expression levels and IgA nephropathy complicated with hyperuricemia
    Wei Di, Jia Li-min, Zhao Cui, Fang Xiao-fang
    2024, 24(9): 737-742. DOI: 10.3969/j.issn.1671-2390.2024.09.005
    Abstract PDF
    Expressions of serum fibroblast growth factor-23/anti-aging gene Klotho, helper T lymphocyte 1/helper T lymphocyte 2 cytokines in elders with end-stage renal disease and their impacts on the prediction and prognosis of hospital-acquired infection
    Ye Xia, Yang Li-wei, Cai Xue-mei, Tang Qiu-hong, Zhang Cheng-mao
    2024, 24(9): 743-750. DOI: 10.3969/j.issn.1671-2390.2024.09.006
    Abstract PDF
    Regulation of receptor interacting protein kinase 1-mediated apoptosis by cordycepin attenuated hypoxia/reoxygenation-induced renal tubular epithelial cell injury
    Han Xiu-tao, Fan Xiu-zhao, Zhao Zhi-bo, Zhao Jing-yu, Li Jun-hu, Zhang Fang, Jiang Gai-ying, Zhang Li-jun, Chen Fa-hui, Bai Meng-qi, Zhou Xiao-shuang
    2024, 24(9): 751-759. DOI: 10.3969/j.issn.1671-2390.2024.09.007
    Abstract PDF
    Protective effect and mechanism of allicin on renal injury in rats with membranous nephropathy
    Guan Fei-fei, Han Zhao-xu
    2024, 24(9): 760-771. DOI: 10.3969/j.issn.1671-2390.2024.09.008
    Abstract PDF
    Advances of safety of antithrombotic therapy in patients with chronic kidney disease plus atrial fibrillation after percutaneous coronary intervention
    Ning Jia-xuan, Ye Nan, Wang Guo-qin, Bian Wei-jing, Cheng Hong
    2024, 24(9): 772-775. DOI: 10.3969/j.issn.1671-2390.2024.09.009
    Abstract PDF
    Research advances of factors and mechanisms for therapeutic efficacy of rituximab for primary membranous nephropathy
    Liu Yu-ting, Wang Yue
    2024, 24(9): 776-781. DOI: 10.3969/j.issn.1671-2390.2024.09.010
    Abstract PDF
    Recent advances in mechanism and anticoagulant therapy of venous thromboembolism in patients with non-dialysis chronic kidney disease
    Wang Jia-xin, Pan Yang-bin
    2024, 24(9): 782-787. DOI: 10.3969/j.issn.1671-2390.2024.09.011
    Abstract PDF
    Membranous nephropathy plus gastric adenocarcinoma tissue positive for neural epidermal growth factor-like 1:one case report with a literature review
    Yang Wei-dong, Cai Chang, Li Ling-zhi, Wan Qi-jun, Zhang Xiu-li
    2024, 24(9): 788-790. DOI: 10.3969/j.issn.1671-2390.2024.09.012
    Abstract PDF
    Successful treatment of IgA nephropathy complicated by ankylosing spondylitis with recurrent anterior uveitis with adalimumab: one case report
    Wu Jia-biao, Wang Xiao-gang, Chen Zhi-wei
    2024, 24(9): 791-792. DOI: 10.3969/j.issn.1671-2390.2024.09.013
    Abstract PDF